BLFS
Biolife Solutions Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Biolife Solutions Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; of Biolife Solutions Inc's 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Medtronic plc, LivaNova PLC, Integer Holdings Corp and 3 more; of Biolife Solutions Inc's 6 closest co-movers, none share that code.
+2.15%
vs ±5.5% implied · ×0.39
shaded = implied · ▲▼ = realized
Biolife Solutions Inc
39.00
Bull1
Bear2
| Manager | Value | % base | |
|---|---|---|---|
| T. Rowe Price | $190.7M | 13.61% | +3.76% |
| BlackRockindex-like | $180.0M | 12.85% | +4.49% |
| Casdin Capital | $131.5M | 9.38% | −21.86% |
| Invesco | $63.3M | 4.52% | new |
| Vanguardindex-like | $55.5M | 3.96% | +2.42% |
| Manager | Value | % base | |
|---|---|---|---|
| T. Rowe Price | $190.7M | 13.61% | +3.76% |
| BlackRockindex-like | $180.0M | 12.85% | +4.49% |
| Casdin Capital | $131.5M | 9.38% | −21.86% |
| Invesco | $63.3M | 4.52% | new |
| Vanguardindex-like | $55.5M | 3.96% | +2.42% |
Expected move
No implied move.